Document is current
Any future updates will be listed below
-
Authors
Adams, Elizabeth J.
Asad, Sarah
Reinbolt, Raquel
Collier, Katharine A.
Abdel-Rasoul, Mahmoud
Gillespie, Susan
Chen, James L.
Cherian, Mathew A.
Noonan, Anne M.
Sardesai, Sagar
VanDeusen, Jeffrey
Wesolowski, Robert
Williams, Nicole
Shapiro, Charles L.
Macrae, Erin R.
Pilarski, Robert
Toland, Amanda E.
Senter, Leigha
Ramaswamy, Bhuvaneswari
Lee, Clara N.
Lustberg, Maryam B.
Stover, Daniel G. https://orcid.org/0000-0001-9003-8165
-
Funding
Funding for this research was provided by:
Stefanie Spielman Fund (NA)
Pelotonia (NA, NA)
- License Information
-
More Information
Article History
Received: 6 December 2019
Accepted: 26 April 2020
First Online: 6 May 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients completed written informed consent, which included a description of the somatic genomic testing and discussion of study risks and benefits with their treating physician. This study was approved by the Ohio State University Institutional Review Board. Study reference numbers: OSU#2012C0110 and NCT01987726.
: All authors agree with publication. All patient identifying information has been anonymised and there are no identifying images used within the manuscript.
: The funding sources for the study, including Foundation Medicine, Inc., were not involved in the collection, analysis, or interpretation of the data. RW has received research support from Acerta and Astra Zeneca and served on advisory boards for PUMA and Pfizer. Drs. Stover, Lustberg, and Lee had full access to all the data in the study and had final responsibility for the decision to submit for publication.
